Cost pressures in the Canadian hospital drug market, 2006-2014: H82-24/2016-PDF
Pressions sur les coûts du marché pharmaceutique des hôpitaux du Canada, 2006-2014.
"The sale of drugs dispensed in hospitals represents a relatively small component of the Canadian pharmaceutical market (13%), but is nonetheless an emerging market segment. The rates of growth in drug expenditures for in-patient and out-patient settings in Canada are analyzed in this study and compared to foreign markets, with a focus on the impact of high-cost drugs. The analysis provides policy makers with insight into the cost pressures in the Canadian hospital market and illustrates how it compares internationally to the seven Patented Medicine Prices Review Board comparator countries (PMPRB7: France, Germany, Italy, Sweden, Switzerland, the United Kingdom and the United States)."
|Department/Agency||Patented Medicine Prices Review Board.|
|Title||Cost pressures in the Canadian hospital drug market, 2006-2014|
|Subtitle||Pressions sur les coûts du marché pharmaceutique des hôpitaux du Canada, 2006-2014.|
|Language||Bilingual-[English | French]|
|Electronic Document|| |
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact the authoring department to request a format other than those available.
We invite you to consult the Frequently Asked Questions page for additional information regarding the Archived Content notice.
Note: The URLs contained in this/these document(s) may no longer be functional
|Note||Caption title. At head of title: National Prescription Drug Utilization Information System.|
|Number of Pages|| p. :|
|Subject Terms||Health care facilities, Drugs, Prices|
- Date modified: